The Cardinal Health Inc Rollercoaster: What’s Behind the Latest CAH Stock Fluctuation?
Leerink Partners has recently initiated Cardinal Health Inc (CAH) stock to Outperform rating, as announced on February 26, 2024, according to Finviz. Earlier, on February 9, 2024, Argus had raised the stock from a Hold to Buy. Barclays also initiated Overweight rating with a price target of $117. Additionally, Wells Fargo initiated Underweight rating on […]
What’s Causing Cardinal Health Inc (CAH) Stock’s 17.41% Jump Over the Last Six Months?
Leerink Partners has recently initiated Cardinal Health Inc (CAH) stock to Outperform rating, as announced on February 26, 2024, according to Finviz. Earlier, on February 9, 2024, Argus had raised the stock from a Hold to Buy. Barclays also initiated Overweight rating with a price target of $117. Additionally, Wells Fargo initiated Underweight rating on […]
What’s Fueling Cardinal Health Inc (CAH) Stock’s 2.84% Gain Above Its 200-Day SMA?
Leerink Partners has recently initiated Cardinal Health Inc (CAH) stock to Outperform rating, as announced on February 26, 2024, according to Finviz. Earlier, on February 9, 2024, Argus had raised the stock from a Hold to Buy. Barclays also initiated Overweight rating with a price target of $117. Additionally, Wells Fargo initiated Underweight rating on […]
What Factors Have Led to Cardinal Health Inc (CAH) Stock Trading -5.16% Below Its 52-Week High?
Leerink Partners has recently initiated Cardinal Health Inc (CAH) stock to Outperform rating, as announced on February 26, 2024, according to Finviz. Earlier, on February 9, 2024, Argus had raised the stock from a Hold to Buy. Barclays also initiated Overweight rating with a price target of $117. Additionally, Wells Fargo initiated Underweight rating on […]
The Cardinal Health Inc Enigma: What’s Causing the Wild Swings in CAH Stock?
Leerink Partners has recently initiated Cardinal Health Inc (CAH) stock to Outperform rating, as announced on February 26, 2024, according to Finviz. Earlier, on February 9, 2024, Argus had raised the stock from a Hold to Buy. Barclays also initiated Overweight rating with a price target of $117. Additionally, Wells Fargo initiated Underweight rating on […]
Cardinal Health Inc (CAH) Stock Settles at $111.98: What’s Contributing to This Price Point?
Leerink Partners has recently initiated Cardinal Health Inc (CAH) stock to Outperform rating, as announced on February 26, 2024, according to Finviz. Earlier, on February 9, 2024, Argus had raised the stock from a Hold to Buy. Barclays also initiated Overweight rating with a price target of $117. Additionally, Wells Fargo initiated Underweight rating on […]
Cardinal Health Inc (CAH) Stock: More Robust Than the Numbers Suggest?
Leerink Partners has recently initiated Cardinal Health Inc (CAH) stock to Outperform rating, as announced on February 26, 2024, according to Finviz. Earlier, on February 9, 2024, Argus had raised the stock from a Hold to Buy. Barclays also initiated Overweight rating with a price target of $117. Additionally, Wells Fargo initiated Underweight rating on […]
Cardinal Health Inc (CAH) Stock: A Deeper Look at Its True Potential
Leerink Partners has recently initiated Cardinal Health Inc (CAH) stock to Outperform rating, as announced on February 26, 2024, according to Finviz. Earlier, on February 9, 2024, Argus had raised the stock from a Hold to Buy. Barclays also initiated Overweight rating with a price target of $117. Additionally, Wells Fargo initiated Underweight rating on […]
Cardinal Health Inc (CAH) Stock: Surpassing Expectations in the Market?
Leerink Partners has recently initiated Cardinal Health Inc (CAH) stock to Outperform rating, as announced on February 26, 2024, according to Finviz. Earlier, on February 9, 2024, Argus had raised the stock from a Hold to Buy. Barclays also initiated Overweight rating with a price target of $117. Additionally, Wells Fargo initiated Underweight rating on […]
Cardinal Health Inc (CAH) Stock Dilemma: A Surge That Has Everyone Talking—What’s the Real Story?
Leerink Partners has recently initiated Cardinal Health Inc (CAH) stock to Outperform rating, as announced on February 26, 2024, according to Finviz. Earlier, on February 9, 2024, Argus had raised the stock from a Hold to Buy. Barclays also initiated Overweight rating with a price target of $117. Additionally, Wells Fargo initiated Underweight rating on […]
